Oyster Point Pharma, Inc.

Works in Ophthalmology

Oyster Point Pharma, Inc. is a clinical trial sponsor. It has no active clinical trials as lead sponsor; its trials since 2021 were in Ophthalmology. Since 2021 it has completed 10 trials and stopped 1 early.

Trial track record · since 2021

0Active trials0 planned participants
10Completed11 with results posted
1Stopped early9% of finished trials

Pipeline · 0 active trials

No active trials with this company as lead sponsor.

On the market

No marketed products under this name.

Questions about Oyster Point Pharma, Inc

See the rest of this profile

A free account shows the trial list, the financials and the fundraising filings. Pro adds a watchlist: one email when FDA acts on a company you name.

Trial counts are as the sponsor reported them to ClinicalTrials.gov, for trials changed since 2021; latest update 2025-05-06.

Approve Suite is not affiliated with Oyster Point Pharma, Inc..

See something wrong on this page? Write to info@approvesuite.com and we will check it against the source. How corrections work.